datetime,headline,summary,related,lang,source
2020-12-03 09:33:43-05:00,"Home Healthcare Market Latest Innovations, Future Scope and Market Trends | Koninklijke Philips N.V., Air Liquide, Amedisys, Apple Home Healthcare, Arcadia, Davita Inc",Databridgemarketresearch.com Present “Home Healthcare Market– Industry Trends and Forecast to 2027” new report to its research database. The report spread No of pages: 350 No of Figures: 60 No of Tables: 220 in it. Home Healthcare Market latest research report,DVA,en,OpenPR
2020-11-25 11:56:42-05:00,"4.5% CAGR Growth Rate for Dialysis Market BY 2023| Fresenius Medical Care AG & Co. KGaA, Baxter International, Inc., DaVita Inc., Nipro Corporation, B. Braun Avitum","The report provides comprehensive analyses of the top winning strategies, industry dynamics, market size & estimations, key market segments, and competitive landscape. According to the report, the global dialysis market is expected to reach $118.51 billion by 2023 from $91",DVA,en,OpenPR
2020-11-05 00:36:10-05:00,"Home Healthcare Market 2020 High Demand and Forecast Study 2027: Air Liquide, Amedisys, Apple Home Healthcare, Arcadia, Davita Inc, Diaverum, Home Health Care, Inc","Databridgemarketresearch.com announces the release of the report ""Home Healthcare Market"" Size, Share & Trends Analysis Report By 2027. The market data analysed and evaluated in the world class Home Healthcare Market report makes to achieve the business goals and objectives",DVA,en,OpenPR
2020-11-04 12:40:34-05:00,"Home Healthcare Market New Study Reveals to Boost Growth | Leading Players - Koninklijke Philips N.V., Arcadia, Davita Inc, Diaverum, Home Health Care, LHC Group","A market research analysis and estimations carried out in this Home Healthcare Market report aids businesses in gaining knowledge about what is already there in the market, what market looks forward to, the competitive background & steps to be followed",DVA,en,OpenPR
2020-11-03 06:38:22-05:00,"Home Healthcare Market with Covid 19 Analysis and Challenges On Upcoming Trends 2020 || Apple Home Healthcare, Arcadia, Davita Inc, Diaverum, Home Health Care, Inc, Home Healthcare Solutions Company, LLC",Data Bridge Market Research has recently added a concise research on the Home Healthcare Market to depict valuable insights related to significant market trends driving the industry. A market research analysis and estimations carried out in the credible Home Healthcare,DVA,en,OpenPR
2020-11-02 05:47:46-05:00,"Global Renal Dialysis Equipment Market 2020:Business Insights, Size, Trends, Future Assessment, Technology Advancements by B. Braun Melsungen AG,Asahi Kasei Corporation, Allmed Medical Corp, DaVita Inc., MEDIVATORS Inc., NxStage Medical, Inc., TORAY MEDIC","The Renal dialysis equipment used for people whose kidneys not performing functions naturally; it conducts the process of removing excess water, solutes, and toxins from the blood. It is artificial blood purification of acute kidney injuries or end stage renal",DVA,en,OpenPR
2020-10-26 05:09:16-05:00,"Home Healthcare Market 2020 Analysis by Latest COVID19/CORONA Virus Impact with Market Positioning of Key Vendors: Air Liquide, Amedisys, Apple Home Healthcare, Arcadia, Davita Inc, Diaverum, Home Health Care, Inc, Home Healthcare Solutions Company, LLC","Global Home Healthcare Market report brings together a meticulous study of the present and upcoming opportunities to elucidate the future investment in the industry. This report introduces top to bottom evaluation of the industry including empowering technologies, key trends, market",DVA,en,OpenPR
2020-10-24 22:10:42-05:00,$2.94 Billion in Sales Expected for DaVita Inc. (NYSE:DVA) This Quarter,"Wall Street analysts expect DaVita Inc. (NYSE:DVA) to report sales of $2.94 billion for the current quarter, Zacks reports. Six analysts have provided estimates for DaVita’s earnings, with the lowest sales estimate coming in at $2.91 billion and the highest estimate coming in at $3.02 billion. DaVita reported sales of $2.90 billion in the same […]",DVA,en,US Banking News
2020-10-23 02:05:08-05:00,Zacks: Analysts Anticipate DaVita Inc. (NYSE:DVA) Will Announce Earnings of $1.49 Per Share,"Equities analysts predict that DaVita Inc. (NYSE:DVA) will report $1.49 earnings per share (EPS) for the current fiscal quarter, according to Zacks Investment Research. Six analysts have issued estimates for DaVita’s earnings, with the lowest EPS estimate coming in at $1.26 and the highest estimate coming in at $1.63. DaVita posted earnings of $1.53 per […]",DVA,en,US Banking News
2020-10-22 13:48:54-05:00,"Kidney Dialysis Centers Market Share Analysis By 2020-2027: Baxter, B. Braun Melsungen AG, BD, Cantel Medical, DaVita Inc., Diaverum, Dialife SA , Fresenius Medical Care AG & Co. KGaA",Kidney dialysis centers market is expected to gain market growth in the forecast period of 2020 to 2027. Data Bridge Market Research analyses the market to account to growth at a CAGR of 3.3% in the above-mentioned forecast period. The rising,DVA,en,OpenPR
2020-10-22 07:11:47-05:00,"COVID-19 UPDATE: Global Clinical Laboratory Services Market Next Big Thing | Major Giants Laboratory Corporation of America Holding, Quest Diagnostics Incorporated, Spectra Laboratories, DaVita Inc., Eurofins Scientific, UNILABS",DBMR has added a new report titled Global Clinical Laboratory Services Market with data Tables for historical and forecast years represented with Chats & Graphs spread through Pages with easy to understand detailed analysis. This Global Clinical Laboratory Services Market,DVA,en,OpenPR
2020-10-22 05:07:33-05:00,"Global Home Healthcare Market 2020-2026 Refreshing Trends || Major Giants – Koninklijke Philips N.V., Air Liquide, Amedisys, Apple Home Healthcare, Arcadia, Davita Inc, Diaverum",Data Bridge Market Research has recently added a concise research on the Home Healthcare Market - Industry Trends and Forecast to 2026. A reliable Home Healthcare Market report contains market data that can be relatively essential when it comes to,DVA,en,OpenPR
2020-10-21 02:50:24-05:00,"Global Renal Dialysis Equipment Market Size, Share, Latest Trends, Demand And Analysis,Forecast 2026||B. Braun Melsungen AG,Asahi Kasei Corporation, Allmed Medical Corp, DaVita Inc., MEDIVATORS Inc., NxStage Medical",Data Bridge Market Research Present “Global Renal Dialysis Equipment Market – Industry Trends and Forecast to 2026” new report to its research database. The report spread No of pages : 350 No of Figures: 60 No of Tables:,DVA,en,OpenPR
2020-10-19 13:27:00-05:00,Short Interest in DaVita Inc. (NYSE:DVA) Decreases By 25.1%,"DaVita Inc. (NYSE:DVA) was the recipient of a large decline in short interest in September. As of September 30th, there was short interest totalling 4,830,000 shares, a decline of 25.1% from the September 15th total of 6,450,000 shares. Approximately 4.1% of the company’s shares are sold short. Based on an average daily volume of 1,100,000 […]",DVA,en,Transcript Daily
2020-10-14 04:46:06-05:00,"COVID-19 Impact On Global Home Healthcare Market Surprising Growth due to Covid 19 include Major Players Koninklijke Philips N.V., Air Liquide, Amedisys, Apple Home Healthcare, Arcadia, Davita Inc, Diaverum, Home Health Care, Inc, Home Healthcare Solution",Data Bridge Market Research has recently added a concise research on the Global Home Healthcare Market to depict valuable insights related to significant market trends driving the industry. Global Home Healthcare Market report comprises of crucial aspects of the market that,DVA,en,OpenPR
2020-10-07 16:21:19-05:00,"COVID-19 UPDATE: Global Home Healthcare Market Likely to Experience a Tremendous Growth in Near Future||Koninklijke Philips N.V., Air Liquide, Amedisys, Apple Home Healthcare, Arcadia, Davita Inc, Diaverum, Home Health Care, Inc","Home Healthcare Market research report has been prepared with a nice combination of industry insight, smart solutions, practical solutions and newest technology to give better user experience. Under market segmentation chapter, research and analysis is done based on several market",DVA,en,OpenPR
2020-10-06 02:56:57-05:00,"Global Renal Dialysis Equipment Market To Eyewitness Immense Growth By 2026 || B. Braun Melsungen AG,Asahi Kasei Corporation, Allmed Medical Corp, DaVita Inc., MEDIVATORS Inc., NxStage Medical, Inc","“Global Renal Dialysis Equipment Market–Industry Trends and Forecast to 2026” Comprehensive Research Report to Added In Databridgemarketresearch.com directory. Report carrying 350 pages, 60 Figures And 220 Tables in it. Global Renal Dialysis Equipment Market Statistical Overview Report 2019 gives an",DVA,en,OpenPR
2020-09-28 08:16:41-05:00,Insider Weekends: Henry Samueli Buys $37 Million Worth Of Broadcom,"Insider buying increased last week. Notable Insider Buys: Broadcom Inc., TravelCenters of America Inc., Kingsway Financial Services Inc., DaVita Inc., CB Financial Services, Inc.",DVA,en,Seeking Alpha
2020-09-21 16:00:21-05:00,Berkshire Hathaway reduced stake in DaVita HealthCare Partners Inc,https://www.investing.com/news/stock-market-news/berkshire-hathaway-reduced-stake-in-davita-healthcare-partners-inc-2302610,DVA,en,Investing.com
2020-09-17 05:00:00-05:00,DaVita Announces Final Results Of Self-Tender Offer,"DENVER, Sept. 17, 2020 /PRNewswire/ -- DAVITA INC. (NYSE: DVA) (""DaVita"") a health care provider focused on transforming care delivery to improve quality of life for patients globally and one of the largest providers of kidney care services in the United States, announced today the final…",DVA,en,PR Newswire
2020-09-15 05:30:00-05:00,DaVita Announces Preliminary Results of Self-Tender Offer,"DENVER, Sept. 15, 2020 /PRNewswire/ -- DAVITA INC. (NYSE: DVA) (""DaVita""), a health care provider focused on transforming care delivery to improve quality of life for patients globally and one of the largest providers of kidney care services in the United States, announced today the…",DVA,en,PR Newswire
2020-09-08 05:00:00-05:00,DaVita Announces Shawn Guertin Will Join its Board of Directors,"DENVER, Sept. 8, 2020 /PRNewswire/ -- DaVita Inc. announced today that its Board of Directors appointed a new independent director, Mr. Shawn Guertin, to join the Board, effective Sept. 15. Mr. Guertin joins the Board with nearly 35 years of health care experience. Most recently, Mr….",DVA,en,PR Newswire
2020-08-17 05:16:10-05:00,DaVita launches $1 billion stock buyback offer,"Shares of DaVita Inc. undefined rallied 2.7% in premarket trading Monday, after the kidney services provider said it has launched a tender to buy back up $1…",DVA,en,MarketWatch
2020-08-17 03:00:00-05:00,DaVita Commences Self-Tender Offer To Purchase For Cash Shares Of Its Common Stock,"DENVER, Aug. 17, 2020 /PRNewswire/ -- DaVita Inc. (NYSE: DVA) (""DaVita""), a health care provider focused on transforming care delivery to improve quality of life for patients globally and one of the largest providers of kidney care services in the United States, announced today that it…",DVA,en,PR Newswire
2020-08-11 03:30:00-05:00,DaVita Announces Paula A. Price to Join its Board of Directors,"DENVER, Aug. 11, 2020 /PRNewswire/ -- DaVita Inc. (NYSE: DVA) announced today that its Board of Directors appointed a new independent director, Ms. Paula A. Price, to join the Board, effective September 1, 2020. ""We are very excited to have Paula, a seasoned financial strategist, join the…",DVA,en,PR Newswire
2020-08-06 17:01:00-05:00,DaVita Inc. Announces Pricing of $1.5 Billion Senior Notes Offering,"DENVER, Aug. 6, 2020 /PRNewswire/ -- DaVita Inc. (NYSE: DVA) (""DaVita"") announced today the pricing of its previously announced private offering of $1.5 billion aggregate principal amount of senior notes due 2031 (the ""2031 notes""). The 2031 notes were priced at 100% of their face amount…",DVA,en,PR Newswire
2020-08-06 06:27:00-05:00,DaVita Inc. Announces Offering of $1.5 Billion Senior Notes,"DENVER, Aug. 6, 2020 /PRNewswire/ -- DaVita Inc. (NYSE: DVA) (""DaVita"") announced today that it has commenced a private offering of $1.5 billion aggregate principal amount of senior notes due 2031 (the ""2031 notes""), subject to market and other conditions. Prior to the closing date of…",DVA,en,PR Newswire
2020-07-30 15:01:00-05:00,DaVita Inc. 2nd Quarter 2020 Results,"DENVER, July 30, 2020 /PRNewswire/ -- During the second quarter of 2020, DaVita (NYSE: DVA) remained focused on its top priorities, the safety and care of its patients, caregivers, teammates and physician partners. In the face of the novel coronavirus (COVID-19) pandemic, we continue to…",DVA,en,PR Newswire
2020-07-15 15:01:00-05:00,DaVita Inc. Schedules 2nd Quarter 2020 Investor Conference Call,"DENVER, July 15, 2020 /PRNewswire/ -- DaVita Inc. (NYSE: DVA), announced today that it will hold its quarterly conference call to discuss second quarter results on Thursday, July 30, 2020, at 5:00 p.m. Eastern Time. The company plans to release its results after market close the same day….",DVA,en,PR Newswire
2020-06-15 09:01:00-05:00,Vox Royalty Strengthens Management Team with Addition of Experienced CFO and General Counsel and Annnounces Investor Relations Partnership with Adelaide Capital,"/NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES / TORONTO , June 15, 2020 /CNW/ - Vox Royalty Corp. (TSXV: VOX ) (""Vox"" or the ""Company"") is pleased to announce the appointment of Pascal Attard as Chief Financial Officer effective immediately. Mr. Attard joins with broad experience in accounting and corporate finance, most recently serving as the Chief Financial Officer of Delivra Corp. until November 2019 . Mr. Attard stated: ""I am excited to contribute to the strategic vision of the Vox Royalty leadership team as the Company continues to execute its industry-leading growth strategy in the mining royalty space"". Pascal held the position of Chief Financial Officer of Delivra Corp. until November 2019 , where he had a broad scope of authority, including executive guidance for finance, accounting, contracts, treasury, taxation, mergers and acquisitions and investor relations. Mr. Attard played a key role in successfully guiding the company through the …",DVA,en,Benzinga Feeds
2020-05-26 17:05:00-05:00,DaVita Inc. Announces Pricing of $1.75 Billion Senior Notes Offering,"DENVER, May 26, 2020 /PRNewswire/ -- DaVita Inc. (NYSE: DVA) (""DaVita"") announced today the pricing of its previously announced private offering of $1.75 billion aggregate principal amount of senior notes due 2030 (the ""2030 notes""). The 2030 notes were priced at 100% of their face amount…",DVA,en,PR Newswire
2020-05-26 07:30:00-05:00,DaVita Inc. Announces Offering of $1.75 Billion Senior Notes,"DENVER, May 26, 2020 /PRNewswire/ -- DaVita Inc. (NYSE: DVA) (""DaVita"") announced today that it has commenced a private offering of $1.75 billion aggregate principal amount of senior notes due 2030 (the ""2030 notes""), subject to market and other conditions. Prior to the closing date of…",DVA,en,PR Newswire
2020-05-05 15:01:00-05:00,DaVita Inc. COVID-19 Response Efforts and 1st Quarter 2020 Results,"DENVER, May 5, 2020 /PRNewswire/ -- During the first quarter of 2020, DaVita Inc. (NYSE: DVA) took significant steps to respond to the novel coronavirus (COVID-19) pandemic while continuing to provide high-quality care for its patients whose lives depend on receiving dialysis treatment…",DVA,en,PR Newswire
2020-03-31 16:50:10-05:00,DaVita HealthCare (DVA) Stock Moves -0.46%: What You Should Know,"DaVita HealthCare (DVA) closed the most recent trading day at $76.06, moving -0.46% from the previous trading session.",DVA,en,Zacks Investment Research
2020-03-18 16:45:21-05:00,DaVita HealthCare (DVA) Gains As Market Dips: What You Should Know,"DaVita HealthCare (DVA) closed at $75.27 in the latest trading session, marking a +0.19% move from the prior day.",DVA,en,Zacks Investment Research
2020-03-11 10:30:22-05:00,DaVita HealthCare (DVA) Down 12.2% Since Last Earnings Report: Can It Rebound?,DaVita HealthCare (DVA) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.,DVA,en,Zacks Investment Research
2020-01-24 10:37:09-05:00,"Goldman Sachs Upgrades Davita, Poised To Profit From Medicare Expansion","Davita Inc (NYSE: DVA ) surged to all-time highs Friday after winning the praise of a new market advocate. Medicare is largely to thank. The Rating Goldman Sachs analysts led by Stephen Tanal upgraded Davita to Buy and raised their price target from $72 to $97. The Thesis Next year, the U.S. will expand eligibility for Medicare Advantage plans to people with preexisting end stage renal disease (ESRD). As of yet, the program captures only the ESRD patients who developed the disease after enrollment or who were eligible for special needs dialysis plans. “The 2021 ESRD rule change carries implications across the healthcare services ecosystem, as the 516,000 patients on Medicare with ESRD represent just 1% of all Medicare-eligibles but approximately 7% of … Full story available on Benzinga.com",DVA,en,Benzinga
2019-12-05 11:31:02-05:00,Why Is DaVita HealthCare (DVA) Up 2.9% Since Last Earnings Report?,DaVita HealthCare (DVA) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.,DVA,en,Zacks Investment Research
2019-11-05 17:25:08-05:00,DaVita HealthCare (DVA) Surpasses Q3 Earnings and Revenue Estimates,"DaVita HealthCare (DVA) delivered earnings and revenue surprises of 24.39% and 1.81%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?",DVA,en,Zacks Investment Research
2019-10-12 13:19:17-05:00,Hedge Fund Sentiment Unchanged On DaVita Inc (DVA),"We know that hedge funds generate strong, risk-adjusted returns over the long run, therefore imitating the picks that they are collectively bullish on can be a profitable strategy for retail investors. With billions of dollars in assets, smart money investors have to conduct complex analyses, spend many",DVA,en,ACI Information Group
2019-08-31 08:31:53-05:00,Why Is DaVita HealthCare (DVA) Down 5% Since Last Earnings Report?,DaVita HealthCare (DVA) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.,DVA,en,Zacks Investment Research
2019-08-08 09:20:10-05:00,Why DaVita HealthCare (DVA) Might be Well Poised for a Surge,"DaVita HealthCare (DVA) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.",DVA,en,Zacks Investment Research
2019-08-01 16:15:03-05:00,DaVita HealthCare (DVA) Q2 Earnings Top Estimates,"DaVita HealthCare (DVA) delivered earnings and revenue surprises of 10.91% and -0.17%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?",DVA,en,Zacks Investment Research
2019-07-25 09:33:55-05:00,DaVita HealthCare (DVA) Earnings Expected to Grow: Should You Buy?,DaVita HealthCare (DVA) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.,DVA,en,Zacks Investment Research
2019-07-22 06:40:00-05:00,DaVita's stock rallies after profit outlook raised,"Shares of DaVita Inc. rallied 4.2% in premarket trading Monday, after the dialysis services company raised its profit outlook, as it looks to update…",DVA,en,MarketWatch
2019-07-13 08:11:00-05:00,"Trump took 3 big losses on healthcare this week, and the losing streak probably isn't going to end anytime soon","Donald Trump keeps losing the war to lower healthcare costs, this week alone losing three key battles against Big Pharma and other healthcare companies. The White House has said that it has more plans to lower costs in the works, but the ones it has are extremely divisive within the President's own party. That means getting them across the finish line will be hard. And we have yet to see proof that this administration can do hard. Big healthcare companies handed the White House three major losses in its quest to lower drug prices this week, and the way things are going it doesn't look the Trump administration has any sure-fire plan for victory any time soon. Loss 1: A judge ruled that the White House had to scrap its rule forcing drug companies to disclose prices in commercials. The judge said the White House lacked the authority to make this rule in the first place after after three pharmaceutical firms sued over the measure. Loss 2: The White House announced its plan to lower the cost of dialysis, a business so costly and corrupt that HBO's Last Week Tonight with John Oliver did a segment on it.",DVA,en,Business Insider
2019-07-10 12:26:00-05:00,"DaVita, American Renal stocks bounce after President Trump signs executive order on kidney disease","Shares of DaVita Inc. bounced 4.3% in afternoon trading Wednesday, after President Trump signed an executive order on kidney disease, aimed at cutting costs…",DVA,en,MarketWatch
2019-07-10 11:37:00-05:00,"Trump just announced a new approach to caring for millions of people with a devastating disease, and it could upend a $114 billion market","President Donald Trump will release an executive order today that could transform care for people with kidney disease. The goal is to encourage more home-based kidney care and to lower the burden on the Medicare budget. Medicare pays for most care for people with severe kidney disease. Around 37 million people in the US have kidney disease with 12% using home-based kidney care. The Trump administration wants to increase this number to 80% by 2025. Analysts at SVB Leerink, led by Ana Gupte, said that some big health insurers like CVS Health and UnitedHealth Group stand to benefit from the executive order. Click here for more BI Prime stories. President Donald Trump just signed an executive order that could transform how the US cares for people with a costly and devastating disease. Trump's order encourages more home-based care for people with kidney disease, with the goal of lowering US spending on people whose kidneys aren't working. The US government pays for the vast majority of care for people with failing kidneys through the Medicare program.",DVA,en,Business Insider
2019-06-06 08:31:24-05:00,Why Is DaVita HealthCare (DVA) Down 9.9% Since Last Earnings Report?,DaVita HealthCare (DVA) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.,DVA,en,Zacks Investment Research
2019-05-31 03:00:21-05:00,Delivra reports Q1 results,No summary available.,DVA,en,Seeking Alpha
2019-05-29 14:07:49-05:00,"Noteworthy Wednesday Option Activity: DVA, JNJ, DE",Among the underlying components of the S amp P 500 index we saw noteworthy options trading volume today in DaVita Inc Symbol DVA where a total of 22 033 contracts have traded so far representing approximately 2 2 million underlying shares That amounts to about 139 3 of DVA s average,DVA,en,Nasdaq
2019-05-07 21:46:06-05:00,DaVita HealthCare Partners Inc. (DVA) CEO Kent Thiry on Q1 2019 Results - Earnings Call Transcript,"DaVita Inc. (NYSE:DVA) Q1 2019 Earnings Conference Call May 07, 2019 5:00 PM Company Participants Jim Gustafson - Vice President, Investor Relations Kent Thiry",DVA,en,Seeking Alpha
2019-05-07 16:45:05-05:00,DaVita HealthCare (DVA) Q1 Earnings and Revenues Miss Estimates,"DaVita HealthCare (DVA) delivered earnings and revenue surprises of -4.21% and -2.74%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock?",DVA,en,Zacks Investment Research
2019-05-07 15:15:55-05:00,"DaVita HealthCare Partners misses by $0.02, misses on revenue",No summary available.,DVA,en,Seeking Alpha
2019-05-06 16:35:37-05:00,DaVita HealthCare Partners Q1 2019 Earnings Preview,No summary available.,DVA,en,Seeking Alpha
2019-04-29 07:21:27-05:00,DaVita's CEO Kent Thiry to transition to executive chairman after 20 years as CEO,"DaVita Inc. said Monday Kent Thiry will step down as chief executive officer, after 20 years in the role, and transition to executive chairman. The kidney care services company said it named Javier Rodriguez, after it has named Javier Rodriguez as its new CEO, effective June 1. Rodriguez was previously CEO of the Kidney Care business since March 2014. DaVita's stock, which was still inactive in premarket trade, has gained 8.1% year to date, while the SPDR Health Care Select Sector ETF has edged up 2.9% and the S&P 500 has climbed 17.3%. Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.",DVA,en,MarketWatch
2019-04-11 06:59:24-05:00,Delivra reports FY results,No summary available.,DVA,en,Seeking Alpha
2019-03-15 14:49:09-05:00,M&A Updates: Harvest One/Delivra Is A Good Looking Nano-Cap Cannabis Merger,No summary available.,DVA,en,Seeking Alpha
2019-03-15 08:30:42-05:00,DaVita HealthCare (DVA) Down 7.8% Since Last Earnings Report: Can It Rebound?,DaVita HealthCare (DVA) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.,DVA,en,Zacks Investment Research
